BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Inflammatory disorder
,
Neuron
,
Personalized medicine
,
Lovastatin
,
rs2300478
,
MYC
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
hemolytic complement
Summary
General Info
Curated Studies
Most Correlated Studies
OMIM - Unspecified immunity deficiency
OMIM - Metabolic disease
CD8+ T cells from blood of CD46-deficient patients activated with antibodies against CD3 and CD46
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
The anaphylatoxin C5a: Structure, function, signaling, physiology, disease, and therapeutics.
Complement Regulation in Human Tenocytes under the Influence of Anaphylatoxin C5a.
Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and…
Characterization of Anaphylatoxin Receptor Expression and C3a/C5a Functions in Anaphylatoxin Recepto…
Anaphylatoxin receptor promiscuity for commonly used complement C5a peptide agonists.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Efficacy and Safety of Iptacopan (LNP023) in Adult Patients With Atypical Hemolytic Uremic Syndrome …
Complement Activation During Hemodialysis in Atypical Hemolytic Uraemic Syndrome as Underlying Kidne…
Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Participants With Aty…
Screening Study to Identify Patients With Complement Factor I Deficiencies
Complement Inhibition in aHUS Dialysis Patients
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ